Media coverage
17
Media coverage
Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet Business Wire Country/Territory United States Date 31/05/23 URL www.businesswire.com/news/home/20230531005476/en/Presentations-at-the-2023-EULAR-European-Congress-of-Rheumatology-Highlight-New-Results-from-Phase-2-Trial-Evaluating-Dazodalibep-in-Sj%C3%B6gren%E2%80%99s-Syndrome/?feedref=JjAwJuNHiystnCoBq_hl-RLXHJgazfQJNuOVHefdHP-D8R-QU5o2AvY8bhI9uvWSD8DYIYv4TIC1g1u0AKcacnnViVjtb72bOP4-4nHK5ieT3WxPE8m_kWI77F87CseT Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren's Syndrome; -- Only Sjögren's syndrome Phase 2 trial to meet the primary endpoint in both patient population types Media name/outlet Business Wire Country/Territory United States Date 31/05/23 URL metabase.moreover.com/noarticleurl?type=psh&lni=68C0-RRM1-DXY3-02R8-00000-00 Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet Street Insider Country/Territory United States Date 31/05/23 URL https://www.streetinsider.com/Press+Releases/Presentations+at+the+2023+EULAR+European+Congress+of+Rheumatology+Highlight+New+Results+from+Phase+2+Trial+Evaluating+Dazodalibep+in+Sj%C3%B6gren%E2%80%99s+Syndrome/21739763.html Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet BioSpace Country/Territory United States Date 31/05/23 URL https://www.biospace.com/article/releases/presentations-at-the-2023-eular-european-congress-of-rheumatology-highlight-new-results-from-phase-2-trial-evaluating-dazodalibep-in-sjoegren-s-syndrome/?s=114 Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren's Syndrome Media name/outlet InvestorsObserver Country/Territory United States Date 31/05/23 URL https://www.investorsobserver.com/news/qm-pr/8586429740901506 Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet ADVFN UK Country/Territory United Kingdom Date 31/05/23 URL https://uk.advfn.com/stock-market/NASDAQ/HZNP/share-news/Presentations-at-the-2023-EULAR-European-Congress/91203876 Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet Yahoo! Finance Country/Territory United States Date 31/05/23 URL https://finance.yahoo.com/news/presentations-2023-eular-european-congress-121000818.html Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet Market Newsdesk Country/Territory United States Date 31/05/23 URL https://www.marketnewsdesk.com/index.php/presentations-at-the-2023-eular-european-congress-of-rheumatology-highlight-new-results-from-phase-2-trial-evaluating-dazodalibep-in-sjogrens-syndrome/ Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjogren's Syndrome Media name/outlet Chase Country/Territory United States Date 31/05/23 URL https://idc.chase.com/newspublic/story?article=5cdb304bbdf637c4&controller=newspublic&action=search&module=default Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet ADVFN US Country/Territory United States Date 31/05/23 URL https://www.advfn.com/p.php?pid=nmona&article=91203876 Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren's Syndrome Media name/outlet Le Lezard.com Country/Territory Canada Date 31/05/23 URL https://www.lelezard.com/en/news-20923484.html Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Media name/outlet Sogotrade - Barchart.com Country/Territory United States Date 31/05/23 URL sogotradedev.websol.barchart.com/?module=topNews&storyID=17326849&selected=news&symbol= Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet Spoke.com Country/Territory United States Date 31/05/23 URL https://www.spoke.com/press_releases/64773e8dfcf26846dc009dfc Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet Pharmaceutical Daily Country/Territory Bosnia and Herzegovina Date 31/05/23 URL https://pharmaceuticaldaily.com/presentations-at-the-2023-eular-european-congress-of-rheumatology-highlight-new-results-from-phase-2-trial-evaluating-dazodalibep-in-sjogrens-syndrome/ Persons Wan Fai Ng Title Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome Media name/outlet CIT Country/Territory United States Date 31/05/23 URL https://www.businesswire.com/news/home/20230531005476/en Persons Wan Fai Ng Title Horizon Therapeutics: Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren’s Syndrome (Businesswire) Media name/outlet Avanza Bank AB Country/Territory Sweden Date 31/05/23 URL https://www.avanza.se/placera/pressmeddelanden/2023/05/31/horizon-therapeutics-presentations-at-the-2023-eular-european-congress-of-rheumatology-highlight-new-results-from-phase-2-trial-evaluating-dazodalibep-in-sjogrens-syndrome.html Persons Wan Fai Ng Title Horizon Therapeutics plc: Presentations at the 2023 EULAR European Congress of Rheumatology Highlight New Results from Phase 2 Trial Evaluating Dazodalibep in Sjögren's Syndrome Media name/outlet FinanzNachrichten.de Country/Territory Germany Date 31/05/23 URL https://www.finanznachrichten.de/nachrichten-2023-05/59223641-horizon-therapeutics-plc-presentations-at-the-2023-eular-european-congress-of-rheumatology-highlight-new-results-from-phase-2-trial-evaluating-dazoda-004.htm Persons Wan Fai Ng